Is there a place for the military in contributing to a global programme managing the MDR-TB challenge and beyond?
Abstract number: R2502
Dhondt E., Peeters T., Laire G.
Background: In accordance with a reorganisation, the Central Military Hospital of the Belgian Defence is looking for new opportunities in cooperation with the civilian health services. Recently a partnership has started with a tertiary care university teaching hospital belonging to a hospital association specialised among others in the treatment of infectious diseases and accredited as a federal SARS reference hospital.
The increasing mean annual incidence of MDR-TB in Belgium (0.1/100,000 inhabitants; 10 new cases annually) and the complex, prolonged and costly management of infected patients (on an average 14 country-wide) urge for a dedicated infrastructure and particular environmental control technologies.
Objective: To study the architectural feasibility of an MDR-TB isolation unit within the existing building of the military hospital.
Methods: A multidisciplinary design team was launched, consisting of critical care and infectious disease specialists, infection control experts and the Defence Operating Engineering staff.
Taking into account the hospital space programming and functional planning and according to the Hospital Law and the CDC guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings (2005), design recommendations and state-of-the-art requirements for an infectious airborne diseases isolation unit were identified. The most suited spatial implantation was subsequently picked out.
Results: Based on the modification of a pre-existing abandoned medium care burn centre, an optimum airborne disease isolation unit design is described. (Figure)
Emphasis is laid on the lay-out of 16 single-patient negative-pressure airborne infection isolation rooms, local exhaust and general ventilation, air cleaning (HEPA filtration), prolonged and socially warranted housing and recreational facilities as well as intensive care, surgery and laboratory capacities.
Conclusion: A dedicated MDR-TB isolation unit is justified.
The Belgian Defence can participate in a global national programme to treat MDR-TB by lending appropriate space and high technical infrastructure to achieve best practice environmental control.
The location in the country's capital permits future centralisation and nation-wide standardisation of protracted MDR-TB chemotherapy and diagnostic drug susceptibility testing.
This project entirely fits in the national contingency planning for the management of emerging airborne infectious diseases like SARS or avian flu.
|Session name:||18th European Congress of Clinical Microbiology and Infectious Diseases|
|Back to top|